Drug application
NORGESTIMATE AND ETHINYL ESTRADIOL (ETHINYL ESTRADIOL, NORGESTIMATE)
Drugs@FDA ANDA 201897 · XIROMED
Key facts
| Drug name | NORGESTIMATE AND ETHINYL ESTRADIOL |
|---|---|
| Active ingredients | ETHINYL ESTRADIOL, NORGESTIMATE |
| Application type | ANDA |
| Application number | 201897 |
| Company | XIROMED |
| Dosage forms | TABLET, ORAL-28 |
| Strength | 0.035MG,0.035MG,0.035MG;0.18MG,0.215MG,0.25MG |
| Marketing status | Discontinued |
| Reference listed drug | No |
| Latest submission class | Not Applicable |
| Latest submission status date | Jan 27, 2016 |
At a glance
- 1–9 Submissions
- 1–9 Supplements
- None Label versions
- 1–9 Products
- None Therapeutic equivalents
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Drugs@FDA applications
Drugs@FDA covers FDA-approved brand-name and generic drugs and therapeutic biologics, with their applications (NDA, ANDA or BLA), products, submissions and labels.